Utility of aspirin in hospitalized COVID-19 patients
A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients
Chapter 3: Professor Casu and Cyclodextrins
Chapter 3 in the recently published book on the history of cyclodextrin is on Professor Benito Casu (1927-2016), who was
Treatment of Niemann-Pick Disease Type C using crosslinked 2-hydroxypropyl-β-cyclodextrin
Niemann-Pick Disease Type C (NPC) is a severe neurovisceral disorder that is pathophysiologically characterized by intracellular transport abnormalities leading to
Technological evolution of cyclodextrins in the pharmaceutical field
Tthe evolution of CD-based pharmaceutical technologies was analyzed, using patent data as the technical source, through a text-mining approach based
Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients
Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s
Hydroxypropyl-β-cyclodextrin causes massive damage to the developing auditory and vestibular system
2-hydroxypropyl-β-cyclodextrin (HPβCD), a cholesterol chelator used to treat Niemann-Pick C1 (NPC1) lysosomal storage disease, causes hearing loss in mammals by
Chapter 2 Professor József Szejtli: The Godfather of Cyclodextrins
Chapter 2 written by Gregorio Crini et al. [1] recalls the memory of Professor Szejtli stating that “no other scientist
Cyclopure’s DEXSORB® adsorbents outperform ion exchange in new study
Removing cationic and zwitterionic compounds extends DEXSORB®’s value proposition to treat polyfluorinated alkyl substances (PFAS) in drinking water The superior
U.S. FDA Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19
— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States — — Veklury Shortened Time to
Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Remdesivir, an investigational broad-spectrum antiviral agent, formulated with sulfobutyl beta-cyclodextrin, has shown in vitro activity against SARSCoV-2. Currently, remdesivir is
Ozone storage in solid form by cyclodextrins
A French research consortium (Institut National Polytechnique de Toulouse, Ecole D’ingenieurs de Purpan, Universite Paul Sabatier Toulouse, Centre National de